These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 38135926)
1. Early Clinical Evaluation of Coronary Artery Lesions in Kawasaki Disease. Shu Z; Deng F; Yang S Clin Pediatr (Phila); 2024 Oct; 63(9):1287-1291. PubMed ID: 38135926 [TBL] [Abstract][Full Text] [Related]
2. Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease. Kitoh T; Ohara T; Muto T; Okumura A; Baba R; Koizumi Y; Yamagishi Y; Mikamo H; Daigo K; Hamakubo T Front Immunol; 2021; 12():624802. PubMed ID: 33912155 [TBL] [Abstract][Full Text] [Related]
3. [Prediction of the risk of coronary arterial lesions in Kawasaki disease by N-terminal pro-brain natriuretic peptide]. Huiling L; Yaping L; Xiufen H Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):300-3. PubMed ID: 26182507 [TBL] [Abstract][Full Text] [Related]
4. Analysis of ultrasound coronary parameters and blood red cell distribution width and N-terminal pro-brain natriuretic peptide concentrations following coronary lesions in children with Kawasaki disease. Gao W; Chen Z; Lu Y; Bai X; Chen M; Lu Y Br J Hosp Med (Lond); 2024 Aug; 85(8):1-10. PubMed ID: 39212580 [No Abstract] [Full Text] [Related]
5. Significance of Serum NT-proBNP and Endogenous H₂S for Predicting Coronary Artery Lesions in Pediatric Kawasaki Disease. Song HB; Zhang YD; Dong QW; Han LP; Qi RF; Bi BB; Ma L; Ma L; Zhang H J Coll Physicians Surg Pak; 2020 Jan; 30(1):37-40. PubMed ID: 31931930 [TBL] [Abstract][Full Text] [Related]
6. N-terminal pro-brain natriuretic peptide and risk of coronary artery lesions and resistance to intravenous immunoglobulin in Kawasaki disease. Yoshimura K; Kimata T; Mine K; Uchiyama T; Tsuji S; Kaneko K J Pediatr; 2013 Jun; 162(6):1205-9. PubMed ID: 23290510 [TBL] [Abstract][Full Text] [Related]
7. Expression of PCT, BNP and Inflammatory Factors in Children with Kawasaki Disease and Their Correlation with Coronary Artery Lesions. Feng H; Chai H; Li D; Shi C; Xu Y; Liu Y Altern Ther Health Med; 2024 Jan; 30(1):302-306. PubMed ID: 37820655 [TBL] [Abstract][Full Text] [Related]
8. Risk of coronary artery lesions in young infants with Kawasaki disease: need for a new diagnostic method. Satoh K; Wakejima Y; Gau M; Kiguchi T; Matsuda N; Takasawa R; Takasawa K; Nishioka M; Shimohira M Int J Rheum Dis; 2018 Mar; 21(3):746-754. PubMed ID: 29105337 [TBL] [Abstract][Full Text] [Related]
9. N-terminal pro-brain natriuretic peptide in acute Kawasaki disease correlates with coronary artery involvement. Adjagba PM; Desjardins L; Fournier A; Spigelblatt L; Montigny M; Dahdah N Cardiol Young; 2015 Oct; 25(7):1311-8. PubMed ID: 25544036 [TBL] [Abstract][Full Text] [Related]
10. Z-score is a possible predictor of the risk of coronary artery lesion development in patients with Kawasaki disease in Japan. Suzuki T; Kakimoto N; Tsuchihashi T; Suenaga T; Takeuchi T; Shibuta S; Kitano N; Suzuki H Eur J Pediatr; 2021 Sep; 180(9):2797-2805. PubMed ID: 33763715 [TBL] [Abstract][Full Text] [Related]
11. Risk factors for coronary artery lesions in children with Kawasaki disease. Duan J; Jiang H; Lu M Arch Argent Pediatr; 2020 Oct; 118(5):327-331. PubMed ID: 32924395 [TBL] [Abstract][Full Text] [Related]
12. Prediction of the risk of coronary arterial lesions in Kawasaki disease by brain natriuretic peptide. Kaneko K; Yoshimura K; Ohashi A; Kimata T; Shimo T; Tsuji S Pediatr Cardiol; 2011 Dec; 32(8):1106-9. PubMed ID: 21487793 [TBL] [Abstract][Full Text] [Related]
13. Neutropenia after intravenous immunoglobulin therapy is associated with coronary artery lesions in children with Kawasaki disease: a case control study. Wang Z; Weng F; Li C; Shi H; Tang Z; Qiu H; He Y; Wu R; Chu M BMC Pediatr; 2018 Feb; 18(1):76. PubMed ID: 29466965 [TBL] [Abstract][Full Text] [Related]
14. Serum Lp-PLA2 Level Predicting Coronary Artery Lesions in Children with Kawasaki Disease. Zhang X; Ya-Wang Shao ; Ya-Lan Zhang ; Yi Liu Heart Surg Forum; 2021 Jul; 24(4):E611-E618. PubMed ID: 34473042 [TBL] [Abstract][Full Text] [Related]
15. Lymphocyte Hydrogen Sulfide Production Predicts Coronary Artery Lesions in Children with Kawasaki Disease: A Preliminary, Single-Center Study. Lin J; Zhao H; Jiao F; Ma L; Wang W; Ma L J Trop Pediatr; 2020 Apr; 66(2):171-177. PubMed ID: 31302704 [TBL] [Abstract][Full Text] [Related]
16. Expression of FcRs on monocytes among Kawasaki disease patients with coronary artery lesions. Xia Y; Tian X; Li Q; Wang G; Li C; Yang J Int Immunopharmacol; 2017 Apr; 45():1-5. PubMed ID: 28147297 [TBL] [Abstract][Full Text] [Related]
17. Elevated Levels of Platelet Activating Factor and Its Acetylhydrolase Indicate High Risk of Kawasaki Disease. Yi L; Zhang J; Zhong J; Zheng Y J Interferon Cytokine Res; 2020 Mar; 40(3):159-167. PubMed ID: 31841639 [TBL] [Abstract][Full Text] [Related]
18. A Comprehensive Assessment of the Value of Laboratory Indices in Diagnosing Kawasaki Disease. Ye Q; Shao WX; Shang SQ; Zhang T; Hu J; Zhang CC Arthritis Rheumatol; 2015 Jul; 67(7):1943-50. PubMed ID: 25778686 [TBL] [Abstract][Full Text] [Related]
19. [Relationship between heart rate variability and coronary artery lesion in children with Kawasaki disease]. Chen TT; Shi K; Liu YL; Guo YH; Li Y; Wang XM Zhongguo Dang Dai Er Ke Za Zhi; 2015 Jun; 17(6):607-12. PubMed ID: 26108324 [TBL] [Abstract][Full Text] [Related]
20. Analysis of Risk Factors for Coronary Artery Lesion in Children with Kawasaki Disease. Bai B; Ya JL; Yan C J Coll Physicians Surg Pak; 2022 Aug; 32(8):1037-1041. PubMed ID: 35932129 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]